CMS proposed rule locks in Medicare Drug Price Negotiation Program

A new proposal from the US Centers for Medicare & Medicaid Services (CMS) would establish a permanent framework for the Medicare Drug Price Negotiation Program (Negotiation Program), creating a more transparent and sustainable process for lowering drug costs for millions of Medicare beneficiaries.

The proposed rule would also create greater long-term certainty for drug manufacturers that participate in negotiations. It includes policies for negotiating and renegotiating high-cost, single-source drugs beginning with initial price applicability year 2029, while continuing to support innovation and strengthen the program.